[Prospective analysis of conservative treatment of acute coronary syndrome]

Kardiologiia
|December 21, 2002
PubMed

Insights

Thrombolysis significantly improved coronary reperfusion and survival rates for acute myocardial infarction (MI) patients compared to heparin and aspirin alone. Conservative interventions show varying outcomes based on treatment and MI type.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Acute coronary syndrome (ACS) management involves various interventions.
  • Conservative (non-invasive) strategies are employed for ACS patients.
  • Understanding outcomes of conservative ACS treatment is crucial for clinical practice.

Purpose of the Study:

  • To analyze in-hospital and intermediate outcomes in ACS patients receiving conservative interventions.
  • To compare the effectiveness of thrombolysis versus heparin and aspirin in acute myocardial infarction (MI).
  • To evaluate survival rates based on treatment strategies and MI subtypes.

Main Methods:

  • Retrospective analysis of 341 patients with ACS.
  • Inclusion of patients treated with conservative (non-invasive) interventions.
  • Comparison of outcomes between thrombolysis and heparin/aspirin groups for MI.
  • Assessment of survival at hospital discharge and 6 months post-intervention.

Main Results:

  • Coronary reperfusion achieved in 59% of MI patients with thrombolysis vs. 27% with heparin/aspirin.
  • In-hospital survival: 91% (thrombolysis) vs. 82% (no thrombolysis).
  • 6-month survival: 86% (thrombolysis) vs. 70% (no thrombolysis), 79% (non-Q-wave MI), 88% (unstable angina).

Conclusions:

  • Thrombolysis demonstrates superior efficacy in achieving coronary reperfusion and improving survival for acute myocardial infarction.
  • Conservative management outcomes vary, highlighting the importance of reperfusion strategies.
  • Further research into optimizing non-invasive ACS treatments is warranted.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...